Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Yongkun Sun"'
Autor:
Hongying Chen, Jinyi Huang, Xiaomeng Li, Weiwei Zhao, Yujie Hua, Zhenfeng Song, Xianwei Wang, Zhikun Guo, Guangdong Zhou, Wenjie Ren, Yongkun Sun
Publikováno v:
Materials Today Bio, Vol 26, Iss , Pp 101051- (2024)
Commonly, articular osteochondral tissue exists significant differences in physiological architecture, mechanical function, and biological microenvironment. However, the development of biomimetic scaffolds incorporating upper cartilage, middle tidema
Externí odkaz:
https://doaj.org/article/7170cb223c7b43a89560c620c804aaa6
Autor:
Wang Qu, Zimin Liu, Xiaobing Chen, Bo Liu, YunBo Zhao, Hao Yan, Xiujuan Qu, Shengmian Li, Aimin Zang, Yongkun Sun, Liangjun Zhu, Aiping Zhou
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Objective To evaluate the efficacy and safety of regorafenib monotherapy or in combination with immune-checkpoint inhibitor while treating Chinese patients with metastatic colorectal cancer (mCRC): a real-world study. Methods The data of pat
Externí odkaz:
https://doaj.org/article/7bbb87cb91cb48f4b2519a41ace9f1ae
Autor:
Wenwei Yang, Dong Chen, Yaru Niu, Guifu Wu, Zhangkan Huang, Xinyu Bi, Hong Zhao, Xu Che, Yongkun Sun
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
PurposeTo explore the efficacy and safety of FOLFOXIRI plus cetuximab regimen as conversion therapy for patients with unresectable RAS/BRAF wild-type colorectal liver-limited metastases (CLM).Patients and methodsThis was a dual-center, phase II trial
Externí odkaz:
https://doaj.org/article/a474726aa473498b8d391eb6fa0e5cff
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
This case report details a patient with Pancreatic Acinar Cell Carcinoma (PACC), a rare malignancy with distinctive biological and imaging features. In the absence of standardized treatment protocols for PACC, we embarked on a diagnostic journey that
Externí odkaz:
https://doaj.org/article/3d9ad6f1e59c4526bf975d614a640fed
Autor:
Zhuanbo Yang, Liming Wang, Yirui Zhai, Jianjun Zhao, Feng Ye, Shulian Wang, Liming Jiang, Yan Song, Yongkun Sun, Ji Zhu, Yuan Tang, Yueping Liu, Yongwen Song, Hui Fang, Ning Li, Shunan Qi, Ningning Lu, Ye-Xiong Li, Hong Zhao, Bo Chen
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 45, Iss , Pp 100749- (2024)
Background: Scarce evidence exists for clinical target volume (CTV) definitions of regional lymph nodes (LNs) in intrahepatic cholangiocarcinoma (iCCA) or combined hepatocellular-cholangiocarcinoma (cHCC-CCA). We investigated the mapping pattern of n
Externí odkaz:
https://doaj.org/article/b0e6fe148a9049fca72dcb21297a7597
Autor:
Wen Zhang, Haitao Zhou, Jun Jiang, Yuelu Zhu, Shuangmei Zou, Liming Jiang, Yuan Tang, Jianwei Liang, Yongkun Sun, Zhichao Jiang, Wang Qu, Ying Li, Aiping Zhou
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Purpose Chemoradiotherapy (CRT) remains the standard treatment for locally advanced rectal cancer (LARC). This phase 2 clinical trial was designed to evaluate the efficacy and safety of neoadjuvant triplet chemotherapy with mFOLFOXIRI (folin
Externí odkaz:
https://doaj.org/article/75ea248036bf4ce0aa752d7f0bcc0e73
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-23 (2022)
Abstract Metastasis is the leading cause of death in colorectal cancer (CRC) patients, and the liver is the most common site of metastasis. Tumor cell metastasis can be thought of as an invasion-metastasis cascade and metastatic organotropism is thou
Externí odkaz:
https://doaj.org/article/117cb6302fa94901a1357fbc2f8f3d8f
Autor:
Caifeng Gong, Wen Zhang, Yongkun Sun, Jianzhong Shou, Zhichao Jiang, Tianyi Liu, Shengzhou Wang, Jun Liu, Ying Sun, Aiping Zhou
Publikováno v:
iScience, Vol 26, Iss 6, Pp 106720- (2023)
Summary: The immune-genetic changes that occur in cancer patients experiencing hyperprogressive disease (HPD) during combined immunotherapy are unclear. In this study, HPD patients with pre- and post-HPD samples and non-HPD patients with solid tumors
Externí odkaz:
https://doaj.org/article/18543e42d8124c869461fbd170d8aaf2
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background SOX (oxaliplatin and S1, every 3 weeks) is one of the most common first-line chemotherapy for advanced or metastatic G/GEJ (gastric or gastroesophageal junction) cancer in Asia, but it has noticeable hematological and neurological
Externí odkaz:
https://doaj.org/article/7d9d1cd1529f4662ba3ead82e2198f9d
A predictive model for early death in elderly patients with gastric cancer: A population-based study
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe mean age of gastric cancer (GC) patients has increased due to the aging society. Elderly GC patients with poor physical status tend to develop complications during the treatment courses, which cause early death. This study aimed to iden
Externí odkaz:
https://doaj.org/article/166df471981f446698012d329e79cc33